Itgam-IRES-DTRGFP
Nomenclature
C57BL/6Smoc-Itgamem1(IRES-DTR-EGFP)Smoc
Cat. NO.
NM-KI-200066
Strain State
Repository Live
Gene Summary
Gene Symbol
Itgam
Model Description
Validation Data
Fig.1 Schematic representation of dosing regimen. Blood samples were taken from the orbital venous plexus before dosing.
Fig.2 Survival rate of Itgam-IRES-DTRGFP mice treated with DT.
Fig.3 The percent of CD11b+ and other immune cells in peripheral blood of HO Itgam-IRES-DTRGFP mice is detected by FACS.
Myeloid cells were significantly reduced 48 hours (D2) after 1st DT administration, and returned 72 hours (D5) after the 2nd DT treatment. However, macrophages were not significantly cleared after DT treatment.
Fig.4 Detection of GFP expression in mCD11b+/mCD14+/mF4/80+ cells in Peripheral blood in WT C57BL/6 and HO Itgam-IRES-DTRGFP (C57BL/6) KI mice in Day 0.
Fig.5 Detection of GFP expression in mCD11b+/mCD14+/mF4/80+ cells in Peripheral blood in WT C57BL/6 and HO Itgam-IRES-DTRGFP (C57BL/6) KI mice in Day 2.
Fig.6 Detection of GFP expression in mCD11b+/mCD14+/mF4/80+ cells in Peripheral blood in WT C57BL/6 and HO Itgam-IRES-DTRGFP (C57BL/6) KI mice in Day 5.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
